Persistierendes Foramen ovale und Schlaganfall

Lernziele

Dieser Fortbildungsartikel gibt einen Überblick über die aktuelle Datenlage zum Thema persistierendes Foramen ovale (PFO) und Schlaganfall. Die Schwerpunkte liegen auf dem Zusammenhang zwischen PFO und erstmaligem zerebrovaskulären Ereignis, dem Schlaganfall-Rezidivrisiko und schließlich der Sekundärprophylaxe.

Literatur

• 1 Cohnheim J. Thrombose und Embolie. Vorlesung über allgemeine Pathologie. Berlin: Hirschwald; 1877: 134
• 2 Lechat P, Mas J L, Lascault G et al. Prevalence of patent foramen ovale in patients with stroke.  N Engl J Med. 1988;  318 1148-1152
• 3 Webster M W, Chancellor A M, Smith H J et al. Patent foramen ovale in young stroke patients.  Lancet. 1988;  2 11-12
• 4 Karamlou T, Diggs B S, Ungerleider R M et al. The rush to atrial septal defect closure: Is the introduction of percutaneous closure driving utilization?.  Ann Thorac Surg. 2008;  86 1584-1590 ; discussion 1590 – 1581
• 5 Hagen P T, Scholz D G, Edwards W D. Incidence and size of patent foramen ovale during the first 10 decades of life: An autopsy study of 965 normal hearts.  Mayo Clin Proc. 1984;  59 17-20
• 6 Di Tullio M R, Sacco R L, Sciacca R R et al. Patent foramen ovale and the risk of ischemic stroke in a multiethnic population.  J Am Coll Cardiol. 2007;  49 797-802
• 7 Meissner I, Khandheria B K, Heit J A et al. Patent foramen ovale: Innocent or guilty? Evidence from a prospective population-based study.  J Am Coll Cardiol. 2006;  47 440-445
• 8 Hansen A, Kuecherer H. Caught in the act: Entrapped embolus through a patent foramen ovale.  Eur J Echocardiogr. 2008;  9 692-693
• 9 Ozdemir A O, Tamayo A, Munoz C et al. Cryptogenic stroke and patent foramen ovale: Clinical clues to paradoxical embolism.  J Neurol Sci. 2008;  275 121-127
• 10 Lamy C, Giannesini C, Zuber M et al. Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: The pfo-asa study. Atrial septal aneurysm.  Stroke. 2002;  33 706-711
• 11 Pezzini A, Del Zotto E, Magoni M et al. Inherited thrombophilic disorders in young adults with ischemic stroke and patent foramen ovale.  Stroke. 2003;  34 28-33
• 12 Lethen H, Flachskampf F A, Schneider R et al. Frequency of deep vein thrombosis in patients with patent foramen ovale and ischemic stroke or transient ischemic attack.  Am J Cardiol. 1997;  80 1066-1069
• 13 Gautier J C, Durr A, Koussa S et al. Paradoxal cerebral embolism: Role of patent oval foramen.  Bull Acad Natl Med. 1990;  174 1031-1038 ; discussion 1038 – 1040
• 14 Ranoux D, Cohen A, Cabanes L et al. Patent foramen ovale: Is stroke due to paradoxical embolism?.  Stroke. 1993;  24 31-34
• 15 Stollberger C, Slany J, Schuster I et al. The prevalence of deep venous thrombosis in patients with suspected paradoxical embolism.  Ann Intern Med. 1993;  119 461-465
• 16 Itoh T, Matsumoto M, Handa N et al. Paradoxical embolism as a cause of ischemic stroke of uncertain etiology. A transcranial doppler sonographic study.  Stroke. 1994;  25 771-775
• 17 Hanna J P, Sun J P, Furlan A J et al. Patent foramen ovale and brain infarct. Echocardiographic predictors, recurrence, and prevention.  Stroke. 1994;  25 782-786
• 18 Klotzsch C, Janssen G, Berlit P. Transesophageal echocardiography and contrast-tcd in the detection of a patent foramen ovale: Experiences with 111 patients.  Neurology. 1994;  44 1603-1606
• 19 Cramer S C, Rordorf G, Maki J H et al. Increased pelvic vein thrombi in cryptogenic stroke: Results of the paradoxical emboli from large veins in ischemic stroke (pelvis) study.  Stroke. 2004;  35 46-50
• 20 Sevitt S, Gallagher N. Venous thrombosis and pulmonary embolism. A clinico-pathological study in injured and burned patients.  Br J Surg. 1961;  48 475-489
• 21 Horton S C, Bunch T J. Patent foramen ovale and stroke.  Mayo Clin Proc. 2004;  79 79-88
• 22 Berthet K, Lavergne T, Cohen A et al. Significant association of atrial vulnerability with atrial septal abnormalities in young patients with ischemic stroke of unknown cause.  Stroke. 2000;  31 398-403
• 23 Handke M, Harloff A, Bode C et al. Patent foramen ovale and cryptogenic stroke: A matter of age?.  Semin Thromb Hemost. 2009;  35 505-514
• 24 Schneider B, Zienkiewicz T, Jansen V et al. Diagnosis of patent foramen ovale by transesophageal echocardiography and correlation with autopsy findings.  Am J Cardiol. 1996;  77 1202-1209
• 25 Thanigaraj S, Valika A, Zajarias A et al. Comparison of transthoracic versus transesophageal echocardiography for detection of right-to-left atrial shunting using agitated saline contrast.  Am J Cardiol. 2005;  96 1007-1010
• 26 Serena J, Marti-Fabregas J, Santamarina E et al. Recurrent stroke and massive right-to-left shunt: Results from the prospective spanish multicenter (codicia) study.  Stroke. 2008;  39 3131-3136
• 27 Overell J R, Bone I, Lees K R. Interatrial septal abnormalities and stroke: A meta-analysis of case-control studies.  Neurology. 2000;  55 1172-1179
• 28 Handke M, Harloff A, Olschewski M et al. Patent foramen ovale and cryptogenic stroke in older patients.  N Engl J Med. 2007;  357 2262-2268
• 29 Petty G W, Khandheria B K, Meissner I et al. Population-based study of the relationship between patent foramen ovale and cerebrovascular ischemic events.  Mayo Clin Proc. 2006;  81 602-608
• 30 Poppert H, Morschhaeuser M, Feurer R et al. Lack of association between right-to-left shunt and cerebral ischemia after adjustment for gender and age.  J Negat Results Biomed. 2008;  7 7
• 31 Alsheikh-Ali A A, Thaler D E, Kent D M. Patent foramen ovale in cryptogenic stroke: Incidental or pathogenic?.  Stroke. 2009;  40 2349-2355
• 32 Mas J L, Arquizan C, Lamy C et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both.  N Engl J Med. 2001;  345 1740-1746
• 33 De Castro S, Cartoni D, Fiorelli M et al. Morphological and functional characteristics of patent foramen ovale and their embolic implications.  Stroke. 2000;  31 2407-2413
• 34 Homma S, Sacco R L, Di Tullio M R et al. Effect of medical treatment in stroke patients with patent foramen ovale: Patent foramen ovale in cryptogenic stroke study.  Circulation. 2002;  105 2625-2631
• 35 Almekhlafi M A, Wilton S B, Rabi D M et al. Recurrent cerebral ischemia in medically treated patent foramen ovale: A meta-analysis.  Neurology. 2009;  73 89-97
• 36 Anzola G P, Zavarize P, Morandi E et al. Transcranial doppler and risk of recurrence in patients with stroke and patent foramen ovale.  Eur J Neurol. 2003;  10 129-135
• 37 Schuchlenz H W, Weihs W, Horner S et al. The association between the diameter of a patent foramen ovale and the risk of embolic cerebrovascular events.  Am J Med. 2000;  109 456-462
• 38 Nedeltchev K, Arnold M, Wahl A et al. Outcome of patients with cryptogenic stroke and patent foramen ovale.  J Neurol Neurosurg Psychiatry. 2002;  72 347-350
• 39 Harrer J U, Wessels T, Franke A et al. Stroke recurrence and its prevention in patients with patent foramen ovale.  Can J Neurol Sci. 2006;  33 39-47
• 40 Orgera M A, O’Malley P G, Taylor A J. Secondary prevention of cerebral ischemia in patent foramen ovale: Systematic review and meta-analysis.  South Med J. 2001;  94 699-703
• 41 Kiblawi F M, Sommer R J, Levchuck S G. Transcatheter closure of patent foramen ovale in older adults.  Catheter Cardiovasc Interv. 2006;  68 136-142 ; discussion 143 – 134
• 42 Anzola G P, Morandi E, Casilli F et al. Does transcatheter closure of patent foramen ovale really “Shut the door?” A prospective study with transcranial doppler.  Stroke. 2004;  35 2140-2144
• 43 Spies C, Khandelwal A, Timmermanns I et al. Incidence of atrial fibrillation following transcatheter closure of atrial septal defects in adults.  Am J Cardiol. 2008;  102 902-906
• 44 Krumsdorf U, Ostermayer S, Billinger K et al. Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1000 consecutive patients.  J Am Coll Cardiol. 2004;  43 302-309
• 45 Wahl A, Krumsdorf U, Meier B et al. Transcatheter treatment of atrial septal aneurysm associated with patent foramen ovale for prevention of recurrent paradoxical embolism in high-risk patients.  J Am Coll Cardiol. 2005;  45 377-380
• 46 Wahl A, Meier B. Patent foramen ovale and ventricular septal defect closure.  Heart. 2009;  95 70-82
• 47 Khairy P, O’Donnell C P, Landzberg M J. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: A systematic review.  Ann Intern Med. 2003;  139 753-760
• 48 Schuchlenz H W, Weihs W, Berghold A et al. Secondary prevention after cryptogenic cerebrovascular events in patients with patent foramen ovale.  Int J Cardiol. 2005;  101 77-82
• 49 Windecker S, Wahl A, Nedeltchev K et al. Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke.  J Am Coll Cardiol. 2004;  44 750-758
• 50 Furlan A, Mauri L, Adams H et al. Late breaking clinical trial and science abstracts from the american heart association’s scientific session 2010; abstract 21 752: Closure i: A prospective, multicenter, randomized, controlled trial to evaluate the safety and efficacy of the starflex® septal closure system versus best medical therapy in patients with a stroke or transient ischemic attack due to presumed paradoxical embolism through a patent foramen ovale.  Circulation research. 2010;  122 2215
• 51 Mono M L, Geister L, Galimanis A et al. Patent foramen ovale may be causal for the first stroke but unrelated to subsequent ischemic events.  Stroke. 2011;  42 2891-2895
• 52 Mattle H P, Meier B, Nedeltchev K. Prevention of stroke in patients with patent foramen ovale.  Stroke. 2010;  5 92-102